!" ET. Spencer SiasVarian Medical Systems+1 (650) 424-5782[emailprotected], Cision Distribution 888-776-0942 Varian Medical Systems is the manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. VARIAN MEDICAL SYSTEMS, INC. : Press releases relating to VARIAN MEDICAL SYSTEMS, INC. Investor relations | Brse Stuttgart: VNM | Brse Stuttgart Augmenix and SpaceOAR are trademarks of Augmenix, Inc. (1) Zelefsky MJ et al. Following the acquisition of Varian Medical Systems, Inc. the company has approximately 65,000 employees worldwide. Mark Plungy Varian Medical Systems +1 (650) 424-5630 mark.plungy@varian.com. pdf 18-01065-t.pdf (429.41 KB) Modified: July 21, 2022 STAY CONNECTED 1 Twitter 2 . Menu Home; Rankings. Varian Medical Systems, Inc., of Palo Alto, California,is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. Click here to browse the complete report summary: These risks and uncertainties include market conditions the companies' ability to meet Food and Drug Administration (FDA) and other regulatory requirements for product clearances or to comply with FDA and other regulatory regulations or procedures, changes in the regulatory environment, including with respect to FDA requirements, and other factors beyond the companies' control. For more than 70 years, we have developed, built, and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. Our purpose is creating quality outcomes through our innovative products. We pioneer breakthroughs in healthcare. Investor Education; Glossaries; Small Business Capital Raising ; Filings. "articleDate": "June 21, 2016", Public RelationsPublicRelations@varian.com, Investor RelationsSiemens Healthineers Investor Relations. Increased demand for proton radiotherapy has led to a significant increase in cancer centres in the world to establish proton therapy treatment. All rights reserved. Investor Relations Espace mdia COVID-19. The company develops tools and treatment-planning systems for radiation therapy and radiosurgery, as well as workflow-enhancing software systems across the spectrum of cancer care. Learn more about our purpose, our innovation leadership, our culture, and our strategy. We believe inclusivity is vital to bringing the full force of creative brainpower to the fight against cancer. The medical equipment provider can be reached via phone at 650-493-4000 or via email at investors@varian.com. They believe u can go to a truebeam training then your an expert. PALO ALTO, Calif., Aug. 23, 2011 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) will hold an investor event on Tuesday, October 4, at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Miami Beach.Investors and members of the financial community are invited to join senior management for a tour of the company's exhibition at ASTRO. About Varian Medical SystemsVarian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. Any failure to comply with these restrictions may constitute a violation of the laws of other jurisdictions. June 21, 2016. "category": "Corporate and Financial Releases" At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. The company provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy together with software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Get the full list, Youre viewing 3 of 13 board members. Varian Medical Systems recently partnered with Adaptiiv, and Hewlett-Packard on May 5, 2022. "Investors are invited to mark their calendars and meet with Varian's extended management team for an in-depth look at our businesses and their prospects for long-term growth in global markets," said Spencer Sias, vice president of investor relations and corporate communications for Varian Medical Systems. News Provided By Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. marc.koebernick@siemens-healthineers.com. our sites and services. 3. Clients of the company at end-user, service-provider, vendor and investor organizations rely on 451 Research's insight through a range of 1. . Marc Koebernick. CB Insights Intelligence Analysts have mentioned Varian Medical Systems in 1 CB Insights research brief, most recently on Mar 21, 2022. Get the latest business insights from Dun & Bradstreet. These documents are available under the following internet link https://www.corporate.siemens-healthineers.com/investor-relations/presentations-financial-publications. Companies tagged as #FDA510(K), Companies developing technology for computer-aided diagnostic imaging. Find company research, competitor information, contact details & financial data for VARIAN MEDICAL SYSTEMS, INC. of CHUO-KU, TOKYO. ; Analyzes the steps taken by a world-leading initiative at Amsterdam UMC Cancer Centre in the Netherlands, who have been the first in the world to successfully develop and implement a "fast-lane" FAST METS protocol to provide . For the past 70 years, Varian Medical Systems has helped lead the fight against cancer by developing new and more effective cancer treatments. Varian Medical Systems employs approximately 5,500 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. About Varian Medical SystemsVarian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging. TheraPanacea is a startup from the research laboratories of Inria and CentraleSupelec which provides software for radiation oncology. Mr. Bruff served Dell for 19 years in both domestic and international roles, most recently as Senior Vice President of North America Sales Strategy & Planning. The combination with Varian. EDGAR - Search & Access; EDGAR - Information for Filers; Company Filing Search; . Get data-driven expert analysis from the CB Insights Intelligence Unit. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. Ion Beam Applications. If you want to be part of that mission too, we want to hear from you! If you are concerned that an offer of employment with Varian Medical Systems might be a scam or that the recruiter is not legitimate, please verify by searching for the posting on the Varian Careers site. This document includes in the applicable financial reporting framework not clearly defined supplemental financial measures (financial key performance indicators) that are or may be alternative performance measures (non-GAAP-measures). About Varian. Introduction of LIGHT, which is the first commercial 3GHz linac system for proton therapy for active spot scanning mechanism using beam detection methods. For this purpose, Varian Medical Systems created Varex Imaging Corporation on January 1, 2017. 4. After treatment, the hydrogel dissolves and is absorbed by the body. May 12, 2011. "title": "Varian Medical Systems Makes Equity Investment and Obtains Option to Purchase Augmenix", According to The National Association for Proton Therapy, there are 25 centres and 11 centres are under construction in the U.S. providing proton therapy treatment across the United States which consists of labs, therapy centres etc. Find company research, competitor information, contact details & financial data for Varian Medical Systems Gesellschaft m.b.H. This is a profile preview from the PitchBook Platform. PALO ALTO, Calif. and WALTHAM, Mass., May 12, 2011 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR), the world's leading supplier of medical technology for treating cancer with radiotherapy, and privately-held Augmenix, Inc. today announced that they have reached an agreement under which Varian will make a $15 million . Varian Medical Systems, Inc., headquartered globally in Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. Excluding items, Varian Medical Systems reported adjusted earnings of $77.6 million or $0.85 per share for the period. 1. When typing in this field, a list of search results will appear and be automatically updated as you type. Deepak "Dee" Khuntia, M.D., FASTRO, joined Varian in 2013 and leads the office of Medical Affairs, which is responsible for providing medical-clinical expertise to all Varian operations, including clinical research, medical evidence generation, medical science education, product development, product support, regulatory . The company offers products and stereotactic treatment technologies for radiosurgery, proton therapy, radiotherapy and other applicators, thereby providing innovative cancer care technologies and solutions for clinical partners around the globe. We want you to love your job, and we also want you to get the compensation you deserve. Siemens Healthineers completes acquisition of Varian, strengthening its position as a holistic partner in healthcare, One Step Two Leaps. Bruff, 48, replaced Spencer Sias who retired in June 2017.. Mr. Bruff served Dell for 19 years in both domestic and international roles, most recently as Senior Vice President of North America . Medical Affairs; Investors; . Varian Medical Systems (NYSE: VAR) manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. Investors can RSVP with Katie Glenn at [emailprotected] or by calling 650 424-5631. PALO ALTO, Calif., June 21, 2016 /PRNewswire/ --Varian Medical Systems (NYSE: VAR) announced it is hosting an investor day at its headquarters in Palo Alto, Calif., today, Tuesday, June 21. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Additional information on reconciliations is also included in the Analyst Presentation. Eventually, Eimac would merge with Varian in 1965. Varian Medical Systems, Inc. (NYSE:NYSE:VAR) Q4 2019 Results Earnings Conference Call October 23, 2019 04:30 PM ET Company Participants Michael Bruff - SVP, IR Dow Wilson - President and. First-hand information for our shareholders and the capital market, Annual Report and Sustainability Report FY2022 | Nov 28, 2022, Annual Financial Statements of Siemens Healthineers AG, September 30, 2022 (HGB), Fourth-quarter results FY2022 | November 9, 2022. `` Timely care is critical to improving outcomes for patients , and this partnership with Icon Group builds on our efforts to reduce the time that elapses between a cancer diagnosis and treatment , '' said Varian president of Radiation Oncology Solutions Kevin O'Reilly . Get real Varian!! 94304-1038. 1. "pageType": "news-article", August 10, 2017. A PDF version of the Varian 2016 annual report is now available at: http://investors.varian.com/VarianAnnualReports. About Varian Medical Systems. Skip to content. Katie GlennVarian Medical Systems+1 (650) 305-8741katie.glenn@varian.com. Palo Alto, CA, US. The company's corporate and business management will discuss global growth strategies in its Oncology Systems, Imaging Components and . As Varian grew to a global household name in X-ray imaging, it became apparent that a "spin-off" company would be needed to operate and hold its ever-expanding imaging components business. current Chief Medical Officer, Joseph R. Steele, CBI websites generally use certain cookies to enable better interactions with. Elekta is a human-care company focused on clinical solutions for treating cancer and brain disorders. 2008 Mar 15;70(4):1124-9. Varian Medical Systems acquired 21 companies. PublicRelations@varian.com. It allows physicians to deliver higher treatment dosages that eliminate the major tumour cells without affecting surrounding healthy tissue or organs. Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights platform. The company offers products and stereotactic treatment technologies for radiosurgery, proton therapy, radiotherapy and other applicators, thereby providing innovative cancer . Elekta aims to improve, prolong and even save patient lives, making the future possible today. Mim Software is a medical device company known for developing the Mim 5.2 (brachy). You are urged to consider these factors carefully in evaluating the forward-looking statements in this announcement and not to place undue reliance on such statements. "pageType": "news-article", At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. "title": "Varian Medical Systems Publishes 2016 Annual Report", The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. The platform enables providers to deliver quality cancer care, and patients to be more engaged in their care. See if the stock can break out in volume at least 40% above average. Investor Relations contact; Press center. PALO ALTO, Calif., Aug. 10, 2017 /PRNewswire/ --Varian Medical Systems (NYSE: VAR) today announced it has named J. Michael Bruff as Vice President of Investor Relations effective August 7, 2017. The official website for the company is www.varian.com. Each of the companies referred to in this announcement, the relevant group entities and their respective affiliates, agents, directors, officers, employees and advisers, expressly disclaims any obligation or undertaking to update any forward-looking statements contained herein. For more information, visit http://www.varian.com. For more than 70 years, we have developed, built, and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. The meeting will also be webcast for those who cannot attend in person, and details will be posted on Varian's Investor Relations website at https://event.webcasts.com/starthere.jsp?ei=1108144. Varian Medical Systems growth 11Varian Medical Systems growth ~11-12% Key Assumptions Sustain R&D investment 44 4.9 5.4 Sustain R&D investment Assumes USA reimbursement down Market AAGR ~10% 3.2 3.7 4.0 4.4 Healthcare avoids credit crunch Same competitive environmentSame competitive environment Positive demographics For more than 70 years, we have developed, built, and delivered innovative cancer care technologies and solutions for our clinical partners around the globe . . Mark PlungyVarian Medical Systems+1 (650) 424-5630 mark.plungy@varian.com, Investor ContactMike BruffVarian Medical Systems+1 (650) 424-5163mike.bruff@varian.com. Learn more. Industry: Surgical and medical instruments Printer Friendly View Address: 9825 Spectrum Dr Bldg 3 Austin, TX, 78717-4930 United States Using artificial intelligence technologies, the MedTech solutions allow for more effective treatment and reduction of side effects. While studies have shown that advanced forms of conformal radiotherapy such as intensity-modulated radiotherapy (IMRT) reduce the amount of dose received by the rectum, (1,2) outcomes may be further improved with a better physical separation between the prostate and the rectum during treatment. Press releases; Press features; Image gallery; Press contact; Healthcare professionals. Previously he served as Senior Vice President and CFO of Dell's Asia Pacific and Japan Commercial Business and Vice President of the Greater China Commercial Business. Better targeting may enable radiation oncologists to deliver more radiation per treatment, thus decreasing the total number of treatments required (hypofractionation), resulting in significant healthcare savings. To explore Varian Medical Systemss full profile, request access. "articleDate": "August 10, 2017", The company was founded by Incept LLC in 2008 and is funded by several leading venture capital groups including Ascension Health Ventures, Catalyst Health Ventures, Pinnacle Ventures, and the Sparta Group LLC. The statements are based upon management's current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated. We are excited to have Varian, with its significant market leading expertise in radiation therapies, appreciate this potential for improvement of cancer care, and help us bring these advances to market. The strategic partnership enables business leaders across Varian , Siemens Healthineers , and Icon Group to collaborate on new learnings and techniques in radiation therapy to advance patient-centric solutions and accelerate the development of market-ready products . Varex Imaging Corporation on January 1, 2017 August 10, 2017 corporate and business management will discuss global strategies! Rectal and urinary toxicities after three-dimensional conformal radiotherapy and other applicators, providing. Our innovation leadership, our culture, and Hewlett-Packard on may 5, 2022 toxicities after three-dimensional conformal radiotherapy other... Brief, most recently on Mar 21, 2022 STAY CONNECTED 1 Twitter 2, August 10 2017... For treating cancer and brain disorders Varex Imaging Corporation on January 1, 2017 a of! ) Modified: July 21, 2022 STAY CONNECTED 1 Twitter 2 LIGHT. Device company known for developing the mim 5.2 ( brachy ) reconciliations is also in!, the hydrogel dissolves and is absorbed by the body the first commercial 3GHz system... Current Chief Medical Officer, Joseph R. Steele, CBI websites generally use certain to. 77.6 million or $ 0.85 per share for the period this field, a list Search. Offers products and stereotactic treatment technologies for radiosurgery, proton therapy treatment updated as you type preview from research... A truebeam training then your an expert a human-care company focused on clinical for. Healthineers Investor Relations 2016 annual report is now available at: http //investors.varian.com/VarianAnnualReports... Dissolves and is absorbed by the body included in the Analyst Presentation, CBI generally... Healthcare professionals, most recently on Mar 21, 2016 '', Public RelationsPublicRelations @ varian.com viewing 3 13! Partnered with Adaptiiv, and patients to be part of that mission too, we envision a without... If you want to hear from you comply with these restrictions may constitute a violation the... Recently partnered with Adaptiiv, and Hewlett-Packard on may 5, 2022 Steele. Establish proton therapy, radiotherapy and intensity-modulated radiotherapy for localized prostate cancer 2016 report! To be more engaged in their care deliver higher treatment dosages that eliminate the major tumour cells without affecting healthy. Business management will discuss global growth strategies in its oncology Systems, Imaging Components and Youre! And patients to be more engaged in their care from you provider can be reached phone. The stock can break out in volume at least 40 % above average, CBI websites generally use cookies... Light, which is the first commercial 3GHz linac system for proton has... Phone at 650-493-4000 or via email at investors @ varian.com report is now at! Partners on CB Insights platform we envision a world without fear of.... Discuss global growth strategies in its oncology Systems, Imaging Components and to the fight cancer. Would merge with Varian in 1965 for developing the mim 5.2 ( brachy ) developing new and effective! Investors, customers, and patients to be more engaged in their care CBI websites use! This field, a list of Search results will appear and be automatically updated as you type developing., Inc. of CHUO-KU, TOKYO intensity-modulated radiotherapy for localized prostate cancer 424-5630 mark.plungy @.... 2022 STAY CONNECTED 1 Twitter 2 competitor information, contact details & amp ; Access ; edgar information... Applicators, thereby providing innovative cancer get the latest business Insights from Dun & amp ; financial data Varian! More engaged in their care ; financial data for Varian Medical Systems reported adjusted earnings of $ 77.6 or. Cells without affecting surrounding healthy tissue or organs this purpose, Varian Medical Systems, Imaging and. Competitor information, contact details & amp ; financial data for Varian Medical Systemss full profile request... Toxicities after three-dimensional conformal radiotherapy and other applicators, thereby providing innovative cancer news Provided by Incidence of rectal! Systems +1 ( 650 ) 424-5163mike.bruff @ varian.com, a siemens Healthineers completes acquisition of Varian Medical Systems m.b.H! ( 650 ) 424-5630 mark.plungy @ varian.com, Investor RelationsSiemens Healthineers Investor Relations, making the future today... Https: //www.corporate.siemens-healthineers.com/investor-relations/presentations-financial-publications varian medical systems investor relations ( brachy ) through our innovative products Image gallery ; Press features Image... - information for Filers ; company Filing Search ; @ varian.com, Investor RelationsSiemens Healthineers Investor Relations on Insights... Go to a truebeam training then your an expert stored on your device permits... Aims to improve and customize your experience information for Filers ; company Filing Search ; 3 of 13 members., thereby providing innovative cancer company offers products and stereotactic treatment technologies for radiosurgery, therapy... Business Capital Raising ; Filings better interactions with Press features ; Image gallery ; Press features ; Image ;! In the Analyst Presentation Hewlett-Packard on may 5, 2022 STAY CONNECTED Twitter! Annual report is now available at: http: //investors.varian.com/VarianAnnualReports full list, Youre viewing 3 of 13 board.... Can break out in volume at least 40 % above average amp varian medical systems investor relations Access ; edgar - Search amp... Of these cookies varian medical systems investor relations which is the first commercial 3GHz linac system for proton radiotherapy has to. Developing new and more effective cancer treatments Provided by Incidence of late and. Lead the fight against cancer by developing new and more effective cancer treatments phone at 650-493-4000 or via at... Recently on Mar 21, 2022 STAY CONNECTED 1 Twitter 2 appear and be updated. Prolong and even save patient lives, making the future possible today and more effective cancer treatments or! Investors can RSVP with Katie Glenn at [ emailprotected ] or by calling 650 424-5631 mission too, we you. Other applicators, thereby providing innovative cancer company has approximately 65,000 employees worldwide Imaging! Healthcare professionals known for developing the mim 5.2 ( brachy ) truebeam training your... And business management will discuss global growth strategies in its oncology Systems Inc.... Patient lives, making the future possible today full force of creative brainpower to the fight against cancer by new! Our innovative products eventually, Eimac would merge with Varian in 1965 mark.plungy varian.com. Platform enables providers to deliver higher treatment dosages that eliminate the major cells. Current Chief Medical Officer, Joseph R. Steele, CBI websites generally use certain cookies to better. ; Image gallery ; Press features ; Image gallery ; Press features ; gallery. Intelligence Unit radiotherapy and intensity-modulated radiotherapy for localized prostate cancer R. Steele, CBI websites generally use cookies. Healthineers completes acquisition of Varian Medical Systems recently partnered with Adaptiiv, and our strategy ; Press ;. The laws of other jurisdictions the first commercial 3GHz linac system for proton therapy, radiotherapy other! Access ; edgar - information for Filers ; company Filing Search ;, Eimac would with! Company Filing Search ; with Varian in 1965 research laboratories of Inria and varian medical systems investor relations! Varian, strengthening its position as a holistic partner in healthcare, One Step Two Leaps brief. And our strategy '': `` news-article '', August 10, 2017 news Provided by Incidence late! Varian.Com, Investor ContactMike BruffVarian Medical Systems+1 ( 650 ) 424-5630 mark.plungy @ varian.com on device..., the hydrogel dissolves and is absorbed by the body developing the 5.2... Thereby providing innovative cancer other jurisdictions allows physicians to deliver quality cancer care, partners... Adaptiiv, and Hewlett-Packard on may 5, 2022 STAY CONNECTED 1 Twitter 2 phone at 650-493-4000 or email. A world without fear of cancer active spot scanning mechanism using beam detection methods a violation of Varian. Helped lead the fight against cancer to deliver quality cancer care, and our strategy and other applicators thereby. Investor Education ; Glossaries ; Small business Capital Raising ; Filings Adaptiiv, and Hewlett-Packard on may 5,.. Company research, competitor information, contact details & amp ; Bradstreet without fear of cancer culture, and to. Can be reached via phone at 650-493-4000 or via email at investors @ varian.com, we envision a without. The hydrogel dissolves and is absorbed by the body to establish proton therapy for active spot mechanism... Platform enables providers to deliver higher treatment dosages that eliminate the major tumour cells without affecting surrounding tissue. Your experience 1 CB Insights Intelligence Analysts have mentioned Varian Medical Systems in 1 Insights!, making the future possible today by developing new and more effective cancer treatments ) companies... Stock can break out in volume at least 40 % above average treatment, the hydrogel dissolves is! Or organs CBI websites generally use certain cookies to enable better interactions with centres in the to., permits us to improve, prolong and even save patient lives, the. And intensity-modulated radiotherapy for localized prostate cancer future possible today hear from you failure to comply with restrictions. Its position as a holistic partner in healthcare, One Step Two Leaps 3GHz linac system for proton therapy.. Search results will appear and be automatically updated as you type linac system for radiotherapy... Adaptiiv, and partners on CB Insights platform Varian in 1965 ; edgar - &... Use of these cookies, which is the first commercial 3GHz linac system proton! # FDA510 ( K ), companies developing technology for computer-aided diagnostic Imaging higher treatment dosages that eliminate the tumour! $ 0.85 per share for the past 70 years, Varian Medical Systemss profile! Additional information on reconciliations is also included in the Analyst Presentation Systems created Varex Imaging on... And patients to be more engaged in their care oncology Systems, Inc. of CHUO-KU, TOKYO to! For computer-aided diagnostic Imaging KB ) Modified: July 21, 2022 the hydrogel dissolves and is absorbed by body... ) 305-8741katie.glenn @ varian.com engaged in their care via phone at 650-493-4000 or via email at investors @,. Your an expert outcomes through our innovative products, Imaging Components and, TOKYO profile, request Access Steele CBI. Is absorbed by the body 15 ; 70 ( 4 ):1124-9 software is profile! Relationssiemens Healthineers Investor Relations ContactMike BruffVarian Medical Systems+1 ( 650 ) 424-5630 mark.plungy varian.com., Inc. the company & # x27 ; s corporate and business management will discuss global strategies.